Saturday 17 October 2026
Export ICU’s income statement to Excel — free account
SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.2 million, up 814.1% from fiscal 2024. In the quarter to June 2026, revenue grew 82.0%, EPS grew 49.4% and free cash flow was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.
2.90
0.16
−5.23%
Follow ICU
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Jan '22 | Dec '21 | Jan '21 | Dec '20 | Jan '20 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | — | — | — | — | — | — | — | — |
P/S ratio |
4.03 | 0.00 | — | — | — | — | — | — | — | — |
Altman Z-Score |
(16.12) | (54.71) | — | — | — | — | — | — | — | — |
P/FCF ratio |
0.00 | 0.00 | — | — | — | — | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
(33.23) | (128.08) | — | — | — | — | — | — | — | — |
P/Operating CF |
(1.22) | (1.55) | — | — | — | — | — | — | — | — |
Beneish M-Score |
5.00 | — | — | — | — | — | — | — | — | — |
P/B ratio |
0.48 | 0.00 | — | — | — | — | — | — | — | — |
Price to Tangible BV |
0.48 | 0.00 | — | — | — | — | — | — | — | — |
EV/Sales |
(3.60) | 0.00 | — | — | — | — | — | — | — | — |
EV/EBITDA |
0.37 | 0.00 | — | — | — | — | — | — | — | — |
EV/Operating CF |
0.33 | (0.50) | — | — | — | — | — | — | — | — |
EV/FCF |
0.33 | (0.50) | — | — | — | — | — | — | — | — |
Quick Ratio |
3.26 | 0.28 | 0.01 | 0.00 | 0.01 | 0.18 | 0.18 | 0.15 | 0.15 | — |
Current Ratio |
3.63 | 0.55 | 0.18 | 0.09 | 0.57 | 0.19 | 0.19 | 0.93 | 0.15 | — |
Net Debt/EBITDA |
0.99 | 0.10 | (0.29) | (0.67) | (0.81) | 0.06 | 0.05 | 7.38 | (16.92) | — |
Debt/Assets |
0.00% | 0.00% | 123.46% | 251.88% | 160.52% | 39.14% | 49.59% | 0.00% | 46.95% | 0.00% |
Debt/Equity |
0.00 | 0.00 | (0.31) | (0.37) | (0.93) | (0.08) | (0.11) | 0.00 | 6.38 | — |
Asset Turnover |
0.13 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
1.12 | 0.64 | 0.39 | 0.64 | 0.34 | 1.11 | 1.11 | 21.73 | 21.73 | — |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | — | — | — |
Interest Coverage |
(392.74) | (73.12) | (13.15) | (18.43) | — | (20.99) | (190.24) | — | — | — |
| (295.15%) | 309.35% | 151.49% | 103.40% | 0.00% | 328.73% | 0.00% | (26.26%) | (26.26%) | — | |
| (129.15%) | (607.76%) | (800.85%) | (669.60%) | 0.00% | (1,053.89%) | 0.00% | (1.93%) | (3.86%) | — | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
(123.50%) | 807.48% | 244.29% | 83.33% | 994.51% | 182.45% | 182.45% | 27.96% | 2.46% | — |
Average Days of Receivables |
70.10 | 302.81 | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Research and Development Expense of Revenue |
609.24% | 6,744.44% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | — | — |
Selling, General and Administrative Expense of Revenue |
473.10% | 6,571.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | 0.00% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
74.72% | 657.04% | 0.00% | 0.00% | — | 0.00% | — | — | — | — |
Graham Net Nets |
1.98 | (0.42) | — | — | — | — | — | — | — | — |
Graham Number |
0.00 | 101.08 | — | — | — | — | — | — | — | — |
Earnings Yield |
(345.83%) | (401.03%) | — | — | — | — | — | — | — | — |
Free Cash Flow Yield |
(273.34%) | (220.62%) | — | — | — | — | — | — | — | — |
Revenue per Share |
0.60 | 0.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF per Share |
(6.56) | (42.80) | (118.63) | (237.62) | (0.95) | (176.34) | (0.39) | (13.14) | (0.01) | — |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Free Cash Flow per Share |
(6.56) | (42.80) | (118.63) | (237.62) | (0.95) | (176.34) | (0.39) | (13.14) | (0.01) | — |
Cash per Share |
5.78 | 4.86 | 2.03 | 1.43 | 0.01 | 17.59 | 0.04 | 4.47 | 0.00 | — |
Shareholders Equity per Share |
5.02 | (5.84) | (159.98) | (632.99) | (1.00) | (97.10) | (0.22) | 2.30 | 0.00 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
5.02 | (5.84) | (159.98) | (632.99) | (1.00) | (97.10) | (0.22) | 2.30 | 0.00 | — |
Free Cash Flow |
(13.60) | (16.01) | (10.28) | (7.79) | (7.79) | (5.11) | (5.11) | (0.11) | (0.11) | — |
Working Capital |
9.84 | (3.07) | (10.74) | (14.63) | (2.31) | (2.52) | (2.52) | (0.02) | (0.21) | — |
Net Current Asset Value |
9.84 | (3.07) | (15.07) | (22.28) | (9.97) | (2.82) | (2.82) | (0.02) | (0.21) | — |
EV/EBIT |
0.36 | 0.00 | — | — | — | — | — | — | — | — |
Capex to Sales |
0.00 | 0.00 | — | — | — | — | — | — | — | — |
Price to Operating Income |
0.00 | 0.00 | — | — | — | — | — | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | — | — | — |
Cash ROIC |
(60.72%) | 4,397.53% | 109.92% | 59.66% | 1,454.10% | 247.05% | 254.81% | (194.16%) | (61.21%) | — |
Accounts Receivable Turnover |
7.07 | 2.18 | — | 0.00 | 0.00 | 0.00 | — | — | — | — |
Accounts Payable Turnover |
0.03 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | 0.00 | — | — |
Inventory Turnover |
0.00 | — | — | — | — | — | — | — | — | — |
Average Days of Payables |
6,528.68 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | 0.00 | — | — |
Days of Inventory on Hand |
454.53 | — | — | — | — | — | — | — | — | — |
Average Receivables |
0.17 | 0.06 | — | 0.04 | 0.04 | 0.06 | — | — | — | — |
Average Payables |
2.00 | 3.71 | 3.15 | 1.01 | — | 0.10 | — | 0.25 | — | — |
Average Assets |
9.41 | 4.09 | 3.28 | 1.82 | 2.69 | 0.44 | 0.44 | 0.27 | 0.13 | — |
Average Common Equity |
4.12 | (8.03) | (17.32) | (11.79) | (5.53) | (1.40) | (1.40) | 0.02 | 0.02 | — |
Columns are period end dates